Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series

Research output: Contribution to journalArticlepeer-review

Abstract

Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.
Original languageEnglish
Pages (from-to)925-929
JournalRESEARCH JOURNAL OF BIOLOGICAL SCIENCES
Volume3(8)
Publication statusPublished - 2008

Fingerprint

Dive into the research topics of 'Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series'. Together they form a unique fingerprint.

Cite this